1 recruiting, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Radiation Retinopathy: new trials by email Literature Review of Radiation Retinopathy trials Research Report on Radiation Retinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy Faricimab, fluocinolone acetonide - Radiation Retinopathy, Visual Impairment | Phase 3 | Recruiting | Jaeb Center for Health Research | 600 | 2023-11-21 | 2026-10-23 |
| Steroids for Early Treatment of Radiation Retinopathy Fluocinolone Acetonide (FA) implant - Radiation Retinopathy | Phase 2 / Phase 3 | Withdrawn | The Cleveland Clinic | 2022-02-01 | 2021-08-04 |
Vision Disorders (1)
Eye Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1) · Signs and Symptoms (1)
Fluocinolone Acetonide (2) · Steroids (1) · faricimab (1)
Jaeb Center for Health Research (1) · The Cleveland Clinic (1)
United States (2)
UG1EY014231 (1)